Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,980 | -38,511 | -42,199 | -44,822 | -142,605 |
| Depreciation Amortization | -350 | 1,507 | 1,556 | 1,962 | 2,494 |
| Accounts receivable | N/A | N/A | N/A | 15,138 | -5,756 |
| Accounts payable and accrued liabilities | 358 | -291 | -1,904 | -2,076 | 3,231 |
| Other Working Capital | -5,521 | -1,779 | 8,895 | 491 | -10,616 |
| Other Operating Activity | 502 | 9,692 | 5,725 | -49,601 | 45,017 |
| Operating Cash Flow | $-31,991 | $-29,382 | $-27,927 | $-78,908 | $-108,235 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 134 | 8 | 76,250 |
| PPE Investments | -15 | -208 | -563 | -199 | -794 |
| Net Acquisitions | N/A | N/A | N/A | 62,908 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -4,653 |
| Investing Cash Flow | $-15 | $-208 | $-429 | $62,717 | $70,803 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 77,782 |
| Debt Repayment | -22,505 | -5,045 | -10,000 | -40,039 | -78,045 |
| Common Stock Issued | 9,207 | 3,471 | 18,582 | 1,337 | 42,817 |
| Other Financing Activity | 1,680 | 31,450 | -76 | 30,760 | 0 |
| Financing Cash Flow | $-11,618 | $29,876 | $8,506 | $-7,942 | $42,554 |
| Beginning Cash Position | 51,181 | 50,895 | 70,745 | 94,878 | 89,756 |
| End Cash Position | 7,557 | 51,181 | 50,895 | 70,745 | 94,878 |
| Net Cash Flow | $-43,624 | $286 | $-19,850 | $-24,133 | $5,122 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,991 | -29,382 | -27,927 | -78,908 | -108,235 |
| Capital Expenditure | -15 | -208 | -610 | -313 | -886 |
| Free Cash Flow | -32,006 | -29,590 | -28,537 | -79,221 | -109,121 |